fig3
Figure 3. Subgroup analyses of recurrence-free survival (A) and overall survival (B). Shared clinicopathological characteristics of CK19-positive and CK19 patients were thoroughly examined. CK19: Cytokeratin 19.
Journal of Cancer Metastasis and Treatment
ISSN 2454-2857 (Online) 2394-4722 (Print)
Navigation
Follow Us
Navigation
Committee on Publication Ethics
https://members.publicationethics.org/members/journal-cancer-metastasis-and-treatment
Portico
All published articles are preserved here permanently:
https://www.portico.org/publishers/oae/
